Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_assertion type Assertion NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_head.
- NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_assertion description "[GPX3 mRNA levels were significantly higher in primary carcinomas and solid metastases from patients who received neoadjuvant chemotherapy compared with chemo-na�ve tumors (P = .016).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_provenance.
- NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_assertion evidence source_evidence_literature NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_provenance.
- NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_assertion SIO_000772 24926085 NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_provenance.
- NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_assertion wasDerivedFrom befree-20150227 NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_provenance.
- NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_assertion wasGeneratedBy ECO_0000203 NP433353.RACy1Tfn2VYMGr80VJ5QHvT6_7F1KLg7z4WXQ_8Akz2CA130_provenance.